Skip to Content

Endovascular Treatment of Aortic Occlusions

December 11, 2019

Efthymios Avgerinos, MD
Associate Professor of Surgery,
UPMC Division of Vascular Surgery

Scott Chapman, MD
UPMC Division of Vascular Surgery

Aortobifemoral bypass has long been considered the gold standard for severe aortoiliac disease (TASC II C and D lesions) and extraanatomic bypass (axillo-bifemoral) was reserved for higher risk patients who would not tolerate a laparotomy. While for simpler (TASC II A and B) lesions, endovascular intervention is well established. There are increasing reports of successful endovascular approaches for TASC II C and D aortoiliac occlusive disease (AIOD). Here we describe two challenging patients with severe AIOD.

Case 1

An 80-year-old female was transferred to UPMC Presbyterian from an outside hospital with rest pain, tissue loss, and a mid-aortic and bilateral common iliac artery occlusion (Figure 1a). She had severe three-vessel coronary disease on recent cardiac catheterization. A hybrid procedure was performed via percutaneous, ultrasound-guided access of right common femoral artery and a left femoral exposure to perform an endarterectomy with profundaplasty given its severe atherosclerotic burden (Figure 1b). The chronic thrombotic occlusions of the iliac arteries and aorta were crossed bilaterally, pre-dilated, and stented. Bilateral balloon-expandable stents were deployed simultaneously in the mid-infrarenal aorta in a parallel kissing stent configuration (Figures 2 a-d), and covered self-expanding stents were utilized for the bilateral external iliac disease. She was discharged home with family a few days following the procedure with resolution of her rest pain.

Case 2

A 63-year-old male was transferred to UPMC Presbyterian from an outside facility with critical limb ischemia and infected axillo-bifemoral bypass with thrombosed fem-fem segment (Figure 3a). The extra-anatomic bypass, which was performed one-year prior for aortic occlusion and rest pain, was chosen as he has a hostile abdomen with multiple operations related to his bladder surgery and radiation.

The infected bypass was removed, and the arteries were repaired with saphenous vein patch angioplasties. Three days later, the infra-renal aorto-iliac occlusion was recanalized via bilateral femoral cut downs and percutaneous left brachial access (Figure 3b-d). Balloon angioplasty was performed, and the occlusion was re-lined with bilateral Viabahn® (W. L. Gore & Associates, Inc., Flagstaff, AZ) 8 mm x 25 mm stents (Figure 3e). The patient was discharged to a skilled nursing facility for four weeks of intravenous antibiotic therapy to treat methicillinsensitive Staphylococcus aureus (MSSA).

He had complete resolution of rest pain and was ambulatory. He will be maintained on life-long oral antibiotic suppressive therapy.


The guidelines by the Trans-Atlantic Inter-Society Consensus regarding the management of AIOD were published in 2007. The guidelines state that open revascularization is favored over endovascular therapy for TASC II D AIOD. The guideline originated from practice patterns, technical considerations, the lower morbidity of endovascular therapies, and the consensus of experts in the field. There was a paucity of data comparing open versus endovascular strategies head-to-head at the time. Over the last 10 years, the endovascular experience and advancement of technology have shifted the treatment paradigm to “endovascular first” strategy for previous arterial lesions in which open surgery in the past was the only consideration.

Figure 1Sachwani et al. compared aortobifemoral (ABF) bypass to percutaneous iliac artery stenting (PCIS) in iliac occlusions. With 100 patients in each treatment arm, the PCIS patients had lower morbidity, shorter length of stay, equivalent secondary patency but inferior primary patency as compared to the ABF cohort. Lun et al. reported one, three, and five-year primary patency rates of chronic infrarenal aortoiliac occlusion of 93.6 percent, 90.2 percent, and 90.2 percent, respectively, in the ABF group, and 91.4 percent, 81.8 percent, and 64.2 percent, respectively, in the endovascular group (p = .054). Again, secondary patency rates were similar, but lower morbidity and shorter hospital stays were associated with the stenting group [9].

Long-term patency of aortoiliac stenting is influenced by distal outflow runoff, the characteristics of the stent, and the anatomic configuration of the iliac stents. Hybrid treatments that include femoral bifurcation open intervention, similar to the cases described, are critical for the durability of aortoiliac stenting. Maurizio et al. reported on 50 patients with TASC II C and D AIOD with a hybrid treatment in 12 of the patients with multi-level disease. The hybrid group’s primary patency was 91.7 percent at one and two years and 80.2 percent at three years with 100 percent secondary patency at one, two, and three years [10].

Figure 2

Exact choice of stent is somewhat controversial. In our opinion, covered balloon-expandable stents in TASC II D AIOD are favorable. In a multicenter, prospective, randomized control trial, Mwipatayi et al. (COBEST trial) demonstrated superior patency results at 12- and 18-months for covered stents as compared to bare-metal stents for TASC II C and D AIOD lesions. The difference in patency results were not observed in TASC II B lesions. By excluding the underlying plaque, covered stents are potentially able to limit late lumen loss seen with bare-metal stents from ongoing inflammation and smooth muscle cell proliferation through the open stent struts. There are two different configurations that are typically used in these cases and are being studied as a factor associated with improved patency for endovascular therapy of extensive AIOD (Figure 4a and 4b). Currently, we deploy the stents simultaneously in a parallel kissing configuration.


Figure 3

In 2013, a new technique using three covered balloon-expandable stents to reconstruct the aortic bifurcation (CERAB– Covered Endovascular Reconstruction of Aortic Bifurcation) was described by Goverde et al. The theoretical advantage of the CERAB technique is lower radial and volume mismatch which provides improved local flow profiles and stent patency. Long-term patency results of the CERAB technique are still to be determined. The kissing stent configuration has improved cost effectiveness by eliminating the need for the large, aortic endograft. The CERAB technique has the disadvantage during aortic deployment of contralateral wire sacrifice and coverage of aortic collateral circulation. Endovascular and hybrid procedures for TASC II C and D AIOD provides patients with a durable result and low risk of surgical complication. The addition of a hybrid procedure improves distal outflow without additional morbidity. The low surgical morbidity, excellent primary and secondary patency rates, and reduced hospital length of stay make it a viable alternative to ABF bypass for TASC II C and D AIOD.

Figure 4



1 Norgren L, Hiatt WR, Dormandy JA, et al.
Inter-society consensus for the management of peripheral artery disease.
Int Angiol 2007;26(2):81-157.

2. Jongkind V, Akkersdijk GJ, Yeung KK, Wisslink W.
A systematic review of endovascular treatment of extensive aortoiliac occlusive disease.
J Vasc Surg 2010;52:1376-83.

3. Ye W, Liu CW, Ricco JB, et al.
Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions.
J Vasc Surg 2011;53:1728-37.

4. Jeffery EI, Miles JP, Forough F, et al.
Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systemic review and meta-analysis.
J Endovasc Ther 2013;20:433-55.

5. Chen TW, Huang CY, Chen PL, Lee CY, Shih, CC, Chen IM.
Endovascular and hybrid revascularization for complicated aorto-iliac occlusive disease: short-term results in single institute experience.
Acta Cardiol Sin 2018;34:313-20.

6. Norgren L, Hiatt WR, Dormandy JA, et al.
Inter-Society Consensus for management of peripheral arterial disease (TASC II).
J Vasc Surg 2007;45SupplS:s5-67.

7. Goodney PP, Beck AW, Nagle J, et al.
National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg 2009;50:54-60.

8. Sachwan GR, Sachinder SH, Khoury MD, King TF, Mitsuya M, Rizk YS, Zachwieja JA, Sayed JA.

Results of iliac stenting and aortofemoral grafting for iliac artery occlusions.
J Vasc Surg 2013;57:1030-37.

9. Lun Y, Zhang J, Xiaoya W, Gang Q, Shea S, Jiang H, Duan Z, Xin S.
Comparison of midterm outcomes between surgical treatment and endovascular reconstruction for chronic infrarenal aortoiliac occlusion.
J Vasc Interv Radiol 2015;26:196-204.

10. Maurizio T, Francesca P, Cristiano F, et al.
Trans-Atlantic Inter-Society Consensus II C and D iliac lesions can be treated by endovascular and hybrid approach: A single-center experience.
Vasc and Endovascular Surg 2014;48:123-128.

11. Mwipaty BP, Thomas S, Wong J, Temple EL, Vijayan V, Jackson M, Burows SA.
A comparison of covered vs. bare expandable stents for the treatment of aortoiliac occlusive disease.
J Vasc Surg 2011;54:1561-70.

12. Goverde PC, Grimme FA, Berbruggen PJ, Reijne MM.
Covered endovascular reconstruction of aortic bifurcation (CERAB) technique: a new approach in treating extensive aortoiliac occlusive disease.
J Cardiovascular Surg 2013;54:383-87.